OmniAb (OABI) Other financing activities (2021 - 2025)
OmniAb's (OABI) quarterly Other financing activities came in at $27.9 million in Q4 2025, up 755.33% year-on-year from $3.3 million in Q4 2024, and up 9279.8% on a QoQ basis from $297000.0 in Q2 2025.
OmniAb (OABI) Other financing activities (2021 - 2025) Analysis & Trends
OmniAb (OABI) has 5 years of Other financing activities data on file, last reported at $27.9 million in Q4 2025.
- On a quarterly basis, Other financing activities rose 755.33% year-over-year to $27.9 million in Q4 2025; TTM through Mar 2026 was $28.2 million, a 1125.2% increase from a year earlier, with the FY2025 full-year figure at $28.2 million, up 765.8% from the prior year.
- Other financing activities for Q4 2025 stood at $27.9 million, up from $297000.0 in the prior quarter.
- Over the last five years, Other financing activities for OABI reached as high as $27.9 million in Q4 2025 and fell as low as -$2.1 million in Q3 2024.
- Historically, Other financing activities has averaged $2.4 million across 5 years, with a median of $297000.0 in 2025.
- On a YoY basis, Other financing activities climbed as much as 1414.88% in 2024 and fell as far as 1234.92% in 2024.
- Year by year, Other financing activities stood at -$1.6 million in 2021, then soared by 138.93% to $624000.0 in 2022, then plunged by 65.54% to $215000.0 in 2023, then surged by 1414.88% to $3.3 million in 2024, then surged by 755.33% to $27.9 million in 2025.
- Per Business Quant data, the three most recent Other financing activities figures were $27.9 million in Q4 2025, $297000.0 in Q2 2025, and $44000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.86 Mn |
| Dec 31, 2025 | 27.86 Mn |
| Jun 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 297,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 3.26 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 215,000.00 |
| Dec 31, 2023 | 215,000.00 |
| Sep 30, 2023 | 189,000.00 |
| Sep 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 615,000.00 |
| Jun 30, 2023 | 615,000.00 |